Immunocore (IMCR) Stock: Buy, Sell, or Hold?
IMCR - Immunocore Holdings plc American Depositary Shares
$32.09
-0.51 (-1.56%)
▼
5d:
+13.23%
30d:
-1.02%
90d:
-9.63%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When IMCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: IMCR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: IMCR shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: IMCR is currently trading at $32.09, which is considered extended relative to its 30-day fair value range of $29.21 to $31.99.
Technical Outlook: Technically, IMCR is showing sideways momentum. Immediate support is located at $27.50, while resistance sits at $33.56.
Market Sentiment: IMCR scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $62.73 (+95.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IMCR is showing sideways momentum. Immediate support is located at $27.50, while resistance sits at $33.56.
Market Sentiment: IMCR scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $62.73 (+95.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$29.21 -
$31.99
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 95.5% below Wall St target ($62.73)
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$29.21 -
$31.99
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$27.50
Resistance Level
$33.57
Current Trend
Sideways
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-42.54
Wall Street Target
$62.73
(+95.5%)
Revenue Growth (YoY)
18.3%
Earnings Growth (YoY)
150.0%
Profit Margin
-4.2%
Share & Embed Analysis
Last updated: October 22, 2026 7:05 AM ET
Data refreshes hourly during market hours. Next update: 8:05 AM
Data refreshes hourly during market hours. Next update: 8:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$295 | 56 HOLD |
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$864 | 47 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 71 BUY |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
20 analysts |
$650 | 50 HOLD |
|
ELVN
Enliven Therapeutics Inc. |
STRONG BUY
14 analysts |
$74 | 63 BUY |
